Jun 27,2022

Cognito Therapeutics Receives $50M from Investors

Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline. Cognito will use the new funding from Menlo Park-based FoundersX to complete clinical trials it can submit to the FDA for approval.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 14,2022

Mental health chatbot Wysa raises $20M

Mental health chatbot Wysa scored $20 million in a Series B financing round led by HealthQuad. Other participants in the raise include British International Investment (BII) and previous investors W Health Ventures, Kae Capital, Google Assistant Investments and pi Ventures.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 20,2022

Healthtech startup Fitterfly raises $12M in Series A round

Healthtech startup Fitterfly has raised $12 million in a Series A round, led by Amazon Smbhav Venture Fund and Fireside Ventures. This follows a $3.1 million in a pre-Series A round it announced last year in April. The latest round takes the total amount raised by the startup to $16.6 million till date. 9 Unicorns, Venture Catalysts, Nihar Parikh of 4point0 Health Ventures, and Sriram Natarajan of Molbio also participated in the round. The Mumbai-based startup will use the capital to enhance its technology stack and branding, and improve the reach of its diabetes management digital therapeutics programme Diabefly.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 13,2022

Smileyscope Raises $4.1M from Investors

Smileyscope received $4.1 million funding acording to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 03,2023

Amalgam Rx raises $17.4M

The document is a Form D filing submitted to the US Securities and Exchange Commission by Amalgam Rx, a healthcare technology company. The filing indicates that Amalgam Rx has raised $17,365,000 USD through the issuance of equity securities to an undisclosed group of investors. The funds raised will be used for working capital and general corporate purposes.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 10,2014

WellDoc raises $20 million from Merck GHI Fund, Windham

Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has landed a $20 million round of investment that includes contributions from Merck Global Health Innovation Fund and Windham Venture Partners. The announcement marks WellDoc's first round of institutional money -- the company has long relied on angel investors and debt -- and now reports total funding at north of $50 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 30,2014

Intuity Medical Raises $5.5M in Debt and Equity Financing

Intuity Medical received $5.5 million in debt and equity rounds according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Mar 14,2014

Intuity Medical Raises $500K in Debt Financing

Intuity Medical received $3.4 million in debt and equity rounds according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Apr 02,2014

Intuity Medical Raises $3.4M in Debt and Equity Financing

Intuity Medical received $500,000 in a debt financing according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Apr 09,2014

Omada Health Closes $23 Million Series B Financing Led by Andreessen Horowitz

Omada Health, a pioneer in the emerging field of digital therapeutics, today announced it has closed $23 million in Series B financing led by Andreessen Horowitz, with participation from Kaiser Permanente Ventures and existing investors including U.S. Venture Partners and The Vertical Group. In addition, Andreessen Horowitz general partner, Balaji S. Srinivasan, will be joining Omada Health’s board of directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING